According to American Thyroid Association (ATA) guideline, papillary thyroid cancer (PTC) with minimal extrathyroidal extension (mETE) is classified at "intermediate risk" of persistent/recurrent disease. However, the impact of mETE per se on patients' outcome is not fully understood. The aim of our study was to evaluate the prognostic significance of mETE in patients with PTC not submitted to therapeutic or prophylactic lymph node dissection, according to tumor size and other prognostic factors.
|Titolo:||Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto: